本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Centessa Pharmaceuticals plc

39.57
+0.09000.23%
盤後39.570.00000.00%16:13 EDT
成交量:237.37萬
成交額:9,360.19萬
市值:61.16億
市盈率:-27.10
高:39.65
開:39.50
低:39.16
收:39.48
52周最高:40.26
52周最低:10.95
股本:1.55億
流通股本:8,933.05萬
量比:0.99
換手率:2.66%
股息:- -
股息率:- -
每股收益(TTM):-1.4600
每股收益(LYR):-1.4600
淨資產收益率:-42.55%
總資產收益率:-20.53%
市淨率:11.61
市盈率(LYR):-27.10

資料載入中...

2024/10/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/18

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/09/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/13

重要事件披露

Form 8-K - Current report
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/10

重要事件披露

Form 8-K - Current report
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/10

重要事件披露

Form 8-K - Current report